Suda, Goki <br/><br/>
The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment.  [electronic resource] 

 -  Internal medicine (Tokyo, Japan)  Apr 2019 
 - 943-947 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1349-7235 
<br/><br/><label>Standard No.: </label>10.2169/internalmedicine.2077-18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aminoisobutyric Acids<br/>Anti-Retroviral Agents--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Carbamates<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Isoquinolines--therapeutic use<br/>Lactams, Macrocyclic<br/>Leucine--analogs & derivatives<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Protease Inhibitors--therapeutic use<br/>Pyrrolidines<br/>Quinoxalines--therapeutic use<br/>Renal Dialysis<br/>Retreatment--methods<br/>Sulfonamides--therapeutic use<br/>Treatment Failure<br/>Valine--analogs & derivatives